Allspring Global Investments’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.29M Sell
161,175
-56,619
-26% -$1.16M 0.01% 961
2025
Q1
$4.36M Buy
217,794
+207,761
+2,071% +$4.16M 0.01% 956
2024
Q4
$267K Buy
10,033
+23
+0.2% +$613 ﹤0.01% 1613
2024
Q3
$285K Sell
10,010
-741
-7% -$21.1K ﹤0.01% 1612
2024
Q2
$234K Sell
10,751
-111
-1% -$2.42K ﹤0.01% 1676
2024
Q1
$241K Buy
10,862
+5,123
+89% +$113K ﹤0.01% 1670
2023
Q4
$124K Buy
5,739
+5,189
+943% +$112K ﹤0.01% 1770
2023
Q3
$9.29K Sell
550
-377,837
-100% -$6.38M ﹤0.01% 2607
2023
Q2
$5.19M Buy
378,387
+9,934
+3% +$136K 0.01% 985
2023
Q1
$8.37M Buy
368,453
+15,623
+4% +$355K 0.01% 835
2022
Q4
$8.31M Buy
352,830
+588
+0.2% +$13.8K 0.01% 830
2022
Q3
$9.19M Sell
352,242
-116,600
-25% -$3.04M 0.02% 804
2022
Q2
$10.3M Buy
468,842
+21,786
+5% +$478K 0.02% 773
2022
Q1
$20.1M Sell
447,056
-5,672
-1% -$254K 0.03% 665
2021
Q4
$19.4M Buy
+452,728
New +$19.4M 0.02% 715